Frost Michael President/Medical Director Frost Medical Group United States In Programme October, 23 10:00 to 19:20 October, 23 17:50 to 19:20 Hours & Dates Wednesday, October 23 10:00 e-poster Adherence to Opioid Use Disorder treatment with an extended-release weekly and monthly injectable buprenorphine 10:00 to 19:20 Digital kiosks Michael Frost Wednesday, October 23 17:50 Short communication Global utilization trends for weekly/monthly injectable buprenorphine (CAM2038) in the treatment of Opioid Use Disorder 17:50 to 19:20 Room 1.06 Michael Frost